1. Hetero Research Foundation (43 from 49 patents)

2. Hetero Drugs Limited (35 from 45 patents)

3. Hetero Labs Limited (7 from 15 patents)

4. Honour (r&d) (3 from 3 patents)

5. Honour Lab Limited (3 from 3 patents)

6. Hetero Research Foundation, Hetero Drugs Limited (2 from 2 patents)

7. Other (1 from 832,398 patents)

8. Dfh Therapeutics, Inc. (1 from 2 patents)

1. 12187740 - Polymorphic forms of bictegravir potassium

2. 12037343 - Process for the preparation of sodium (2r,5s,13ar)-7,9-dioxo-10-((2,4,6,-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13A-octahydro-2,5-methanopyrido[1',2′:4,5]pyrazino[2,1-B] [1,3] oxazepin-8-olate and its polymorphic form

3. 11655220 - Process for the preparation of angiotensin II receptor blockers

4. 11623933 - Process for the preparation of sodium (2R,5S,13AR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl) carbamoyl)-2,3,4,5,7,9,13,13A-octahydro-2,5-Methanopyrido[1 ',2′:4,5]pyrazino[2,1 -b] [1,3] oxazepin-8-olate and its polymorphic form

5. 11434206 - Process for the preparation of diphenylpyrazine derivatives

6. 11053211 - Process for pomalidomide

7. 11034718 - C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors

8. 10934251 - Process for the preparation of lomitapide

9. 10822314 - Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound

10. 10815204 - Process for the preparation of diphenylpyrazine derivatives

11. 10562867 - Process for the preparation of a dual-acting angiotensin receptor-neprilysin inhibitor compound

12. 10533035 - C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors

13. 10464931 - Process for the preparation of Quinolin-2(1H)-one derivatives

14. 10442769 - Process for the preparation of intermediate of dolutegravir

15. 10336706 - Crystalline form of Eltrombopag free acid